Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: Pharmacyclics Inc

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmacyclics Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Pharmacyclics Inc since year 2005. Table 2 shows the detailed insider transactions of Pharmacyclics Inc since 2005. The reporting company's ticker symbol is PCYC. The reporting company's CIK number is 949699.

The total value of stock buying since 2005 is $13,839,093. The total value of stock sales is $0. The total value of stock exercises is $0.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at Pharmacyclics Inc (PCYC) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • $3,834k

    $383k

    $38k

    $3k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Pharmacyclics Inc (PCYC) in the past 24 months. See table 2 for insider transaction details.

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • $4.90

    $3.68

    $2.45

    $1.23



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pharmacyclics Inc (PCYC).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-10 40,500 82,166 0 0 0 0
2008-09 176,065 434,880 0 0 0 0
2008-08 167,242 267,587 0 0 0 0
2008-06 136,418 238,537 0 0 0 0
2008-05 1,982,681 2,081,815 0 0 0 0
2007-09 28,211 72,210 0 0 0 0
2007-08 57,000 118,680 0 0 0 0
2007-02 1,275,381 3,834,884 0 0 0 0
2007-01 108,339 531,131 0 0 0 0
2006-12 31,661 155,218 0 0 0 0
2006-11 455,000 2,175,345 0 0 0 0
2006-09 152,654 709,864 0 0 0 0
2006-08 50,000 215,681 0 0 0 0
2006-07 18,919 67,692 0 0 0 0
2006-05 592,821 2,353,896 0 0 0 0
2006-01 123,000 499,507 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Pharmacyclics Inc (PCYC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-10-01 Rice Glenn C (Director) Purchase 40,500 2.03 82,166
2008-09-05 Duggan Robert W (Director) Purchase 176,065 2.47 434,880
2008-08-22 Duggan Robert W (Director) Purchase 1,200 1.60 1,920
2008-08-21 Duggan Robert W (Director) Purchase 166,042 1.60 265,667
2008-06-26 Duggan Robert W (Director) Purchase 16,300 1.71 27,873
2008-06-25 Duggan Robert W (Director) Purchase 100 1.74 174
2008-06-24 Duggan Robert W (Director) Purchase 38,000 1.87 71,060
2008-06-23 Duggan Robert W (Director) Purchase 82,018 1.70 139,430
2008-05-30 Duggan Robert W (Director) Purchase 1,982,681 1.05 2,081,815
2007-09-07 Duggan Robert W (10% Owner) Purchase 20,433 2.55 52,104
2007-09-05 Duggan Robert W (10% Owner) Purchase 7,778 2.58 20,106
2007-08-22 Miller Richard A Md (Pres, CEO & Director) Purchase 5,000 2.00 10,000
2007-08-22 Lea Leiv (VP Fin & Admin & CFO) Purchase 3,000 2.01 6,029
2007-08-21 Inouye Michael K (Sr. VP, Corp & Comm Dev.) Purchase 20,000 2.04 40,754
2007-08-21 Miller Richard A Md (Pres, CEO & Director) Purchase 5,000 2.00 10,008
2007-08-21 Lea Leiv (VP Fin & Admin & CFO) Purchase 2,000 2.02 4,040
2007-08-14 Duggan Robert W (10% Owner) Purchase 22,000 2.18 47,849
2007-02-21 Duggan Robert W (10% Owner) Purchase 965,000 3.01 2,851,365
2007-01-03 Duggan Robert W (10% Owner) Purchase 108,339 4.90 531,131
2006-12-29 Duggan Robert W (10% Owner) Purchase 31,661 4.90 155,218
2006-11-08 Gilburne Miles R (Director) Purchase 50,000 4.79 239,445
2006-11-08 Duggan Robert W (10% Owner) Purchase 405,000 4.78 1,935,900
2006-09-20 Duggan Robert W (10% Owner) Purchase 23,529 4.89 115,056
2006-09-19 Duggan Robert W (10% Owner) Purchase 19,216 4.76 91,532
2006-09-18 Duggan Robert W (10% Owner) Purchase 17,742 4.75 84,274
2006-09-08 Duggan Robert W (10% Owner) Purchase 8,224 4.80 39,474
2006-09-07 Duggan Robert W (10% Owner) Purchase 19,036 4.61 87,701
2006-09-06 Duggan Robert W (10% Owner) Purchase 3,999 4.52 18,095
2006-09-05 Duggan Robert W (10% Owner) Purchase 36,696 4.46 163,847
2006-09-01 Duggan Robert W (10% Owner) Purchase 20,100 4.48 90,148
2006-08-31 Duggan Robert W (10% Owner) Purchase 50,000 4.31 215,681
2006-07-13 Duggan Robert W (10% Owner) Purchase 18,919 3.58 67,692
2006-05-22 Duggan Robert W (10% Owner) Purchase 96,554 3.95 381,124
2006-05-19 Duggan Robert W (10% Owner) Purchase 100,000 3.94 393,500
2006-05-18 Duggan Robert W (10% Owner) Purchase 198,660 4.00 794,640
2006-01-10 Duggan Robert W (Director) Purchase 80,300 4.18 335,413
2006-01-06 Duggan Robert W (Director) Purchase 25,000 3.93 98,250
2006-01-05 Duggan Robert W (Director) Purchase 17,700 3.72 65,844

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmacyclics Inc (symbol PCYC, CIK number 949699) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.